From corporate giving to foundation grants and employee volunteerism, our approach to #GivingBack is leveraging our resources to drive real and lasting change in our communities. Read more about the ways we give back. #GivesBackWeek
We’re excited to announce that our own Sandra Milan, Senior Group Director Oncology Project Team Leaders, was just named on INvolve’s EMpower 50 Ethnic Minority Future Leaders List. This designation honors role models who are making a significant contribution to ethnic minority #diversity and inclusion at work. Learn more about Sandra and the other honorees. #EMRoleModels19
Recently in MIT Technology Review, our work on personalized cancer vaccines was named on their list of 10 Breakthrough Technologies of 2019. Read why Bill Gates chose to include our research on harnessing the body's natural defenses to target tumors below.
A diverse and inclusive workplace is critical to our mission of helping people with serious diseases. We’re honored to be named a Human Rights Campaign Best Place to Work for LGBTQ Equality. Read more about the 2019 Corporate Equality Index (CEI) below.
Earlier this month we were thrilled to welcome Alexander Hardy as our Chief Executive Officer! Alexander is focused on continuing to foster an environment where scientific innovation can thrive and ensuring patients with serious diseases have access to the breakthrough medicines they need. Learn more about the exciting work we're doing and our commitment to science, patients, and our people by following the link below.
We're grateful to our employees for naming us to Great Place to Work and Fortune's list of 100 Best Companies for more than two decades! Read the full list below.
We're inspired by the many talented people working here to do now what patients need next. Meet some of the faces who motivate us each and every day!
Our ability to bring transformative medicines to patients depends on the positive experience, engagement, and resilience of everyone who works here. Learn more from Nancy Vitale, Senior Vice President, Human Resources, about our holistic approach to wellbeing at work.
We're partnering with Adaptive Biotechnologies—a pioneer in immunosequencing—to develop a type of cellular therapy for cancer that targets #neoantigens. Read more about the science behind our collaboration in "A New Age for Neoantigens."
In case you missed it, our very own Sara Kenkare-Mitra, SVP of Development Sciences was named one of FiercePharma's Fiercest Women in Life Sciences for 2018! This recognition is the product of her trailblazing work in pharmacology and her pursuit of a lifelong dream to deliver medicines to those who need them most. Read more about Sara below.